Three-year-old filly Intravenous is already one step ahead of her Group One-winning sibling Platelet.
Platelet ran second on debut at Echuca but Intravenous was a smart first-up winner at Donald, leaving her one-up on her half-sister.
However, the Darren Weir stable insists that is where the similarities end.
“Intravenous is not as good as Platelet,” Weir’s racing manager Jeremy Rogers said.
“They are a bit different because Intravenous will get over a bit more ground than what Platelet does.”
Intravenous will jump into a benchmark 70 contest when she runs in Wednesday’s Slickpix Handicap (1000m) at Sandown.
The filly defeated her Australasian Oaks-bound stablemate May’s Dream in a barrier trial before her Donald victory.
However, Rogers said Intravenous had things go her way in her maiden win.
“She had a lot of favours that day at Donald but she did win the race in style,” he said.
“It’s a massive rise in class at Sandown but she couldn’t have been more impressive on debut.”
Intravenous has been sent straight to city class in a bid to boost her broodmare value.
Platelet is progressing well ahead of her bid to record back-to-back wins in both the Group One Sportingbet Classic and the Group One Goodwood in Adelaide.
She scored a brilliant first-up win at Moonee Valley on March 21 and Rogers expects the five-year-old has improved from that outing but will benefit from another lead-up run in the RN Irwin Stakes at Morphettville on April 12.
“We are taking exactly the same path with her going into the Sportingbet Classic and the Goodwood,” Rogers said.
Claim $300 in Bonus Bets when you deposit $250!*